Journal Information
Vol. 86. Issue 3.
Pages 110-114 (01 March 2017)
Vol. 86. Issue 3.
Pages 110-114 (01 March 2017)
Original Article
DOI: 10.1016/j.anpede.2016.03.007
Full text access
Adolescent tuberculosis: A challenge and opportunity to prevent community transmission
Tuberculosis en el adolescente; reto y oportunidad de evitar el contagio a la comunidad
Adriana Margarita, Sílvia Simóa, Librada Rozasb, Àngela Deyà-Martíneza, Irene Barrabeigc, Amadéu Genéd, Clàudia Fortunya, Antoni Noguera-Juliana,
Corresponding author

Corresponding author.
a Unitat d’Infectologia, Servei de Pediatria, Hospital Sant Joan de Deú, Universitat de Barcelona, Barcelona, Spain
b Unitat de Referència de Tuberculosi en el Nen, Direcció d’Infermeria, Hospital Sant Joan de Deú, Universitat de Barcelona, Barcelona, Spain
d Servei de Microbiologia, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain
c Unitat de Vigilància Epidemiològica, Regió Barcelona Sud, Agència de Salut Pública de Catalunya, L’Hospitalet de Llobregat, Barcelona, Spain
Article information
Full Text
Download PDF
Tables (1)
Table 1. Main demographic, clinical, radiologic, microbiological characteristics and treatment and outcome of TB disease in the overall case series and in the under-12 and over-12 years age groups.

Adolescents may present with adult-type pulmonary tuberculosis (TB), including cavity disease in upper lobes and smear-positive sputum, which involves a significant transmission risk for social and family contacts.

Patients and methods

A retrospective (2007–2012) observational study of a case series of TB was conducted in children and adolescents (<18 years) in a paediatric referral centre in Barcelona. Patients aged ≤12 and >12 years at diagnosis were compared.


The series consisted of 124 patients (56.5% males, median age: 4.0 years). In half of the cases, the patient was of immigrant origin and TB was diagnosed after clinical–radiological suspicion, intra-thoracic disease being the most common (91.9%). Cultures yielded positive results in one third of cases (37.9%) and isolates were sensitive to oral first-line anti-TB agents in 100%. Median (interquartile range) duration of treatment was 6 (6–9) months, directly observed therapy was needed in 10 patients, and there was a satisfactory outcome after treatment in 98.4%. Among adolescents, TB was more prevalent in females (63.2%) and immigrant patients (68.4%), comorbidity at diagnosis and lung cavity forms were more common, and the source case was identified only in 21.1% of the patients.


Adult-type pulmonary TB is common among adolescents, may be associated with underlying medical conditions, and is often diagnosed late, posing a significant transmission risk to the community.

Adult-type disease

La tuberculosis (TB) en el adolescente puede presentar formas radiológicas cavitadas en los lóbulos superiores, con esputos bacilíferos, en lo que se ha llamado TB pulmonar tipo adulto, que implica un importante riesgo de contagio en el entorno social y familiar del paciente.

Pacientes y métodos

Estudio observacional retrospectivo (2007-2012) en una serie pediátrica (<18 años) con TB en un hospital pediátrico de referencia en Barcelona. Se compara a los pacientes12 y>12 años.


Se incluyeron 124 pacientes (56,5% hombres, edad mediana: 4,0 años). En la mitad, la TB afectó a pacientes de origen inmigrante y se diagnosticó por sospecha clínico-radiológica. La TB intratorácica fue la forma clínica predominante (91,9%), los cultivos fueron positivos en un tercio de los casos (37,9%) y sensibles a los fármacos orales de primera línea en su totalidad. El tiempo mediano (rango intercuartil) de tratamiento fue de 6 (6-9) meses; solo 10 pacientes precisaron tratamiento directamente observado y la evolución fue satisfactoria en la mayoría (98,4%). Entre los adolescentes, la TB fue más prevalente en mujeres (63,2%) e inmigrantes (68,4%), la comorbilidad al diagnóstico y las formas pulmonares cavitadas fueron más comunes y se identificó el caso índice solo en el 21,1% de los pacientes.


En el adolescente, la TB pulmonar tipo adulto es común, y a menudo asocia comorbilidad y se diagnostica más tarde, implicando un mayor riesgo de contagio a la comunidad.

Palabras clave:
Enfermedad tipo adulto
Full Text

According to data from the Red Española de Estudio de la Tuberculosis Pediátrica (Spanish Network for the Study of Paediatric Tuberculosis)1 which comprises 73 institutions that treat paediatric patients with tuberculosis (TB) in Spain, 43% of them treat patients aged more than 14 years. This Network is still open to the incorporation of new institutions and researchers (contact, and has prospectively collected data for 340 paediatric patients with TB disease from January to December 2015, of who 65 (19.1%) were older than 12 years at the time of diagnosis. Pulmonary TB in adolescents is sometimes characterised by radiological evidence of cavitation in the upper lung and smear-positive sputum in what has been termed adult-type pulmonary TB (ATpTB).2,3 This study describes the characteristics of a large paediatric series of cases of TB disease, with particular emphasis on adolescent patients.


We conducted a retrospective observational study between January 2007 and December 2012 of a paediatric series (up to 18 years of age) of cases of TB disease in the Hospital Sant Joan de Déu (Barcelona), the tertiary referral hospital for paediatric TB infection in the Barcelona Sud Health Area (population, 1,346,050 inhabitants; 16.5% aged less than 15 years). The study was approved by the Ethics Committee of the Hospital Sant Joan de Déu.

We identified TB cases by searching the hospital diagnosis records and the registry of notifiable diseases of the Department of Public Health. We collected demographic, clinical, radiologic, microbiologic, treatment and outcome data from patient medical records. We classified TB disease based on the scheme proposed by Wiseman et al,4 taking into account not only location (intrathoracic or extrathoracic), but also severity based on disease extent and the associated complications. In our centre, the induction phase (2 months) of anti-TB treatment comprised three drugs (isoniazid, rifampicin and pyrazinamide) until March 2009, after which ethambutol was added to the combination. Maintenance treatment consisted of two drugs (isoniazid and rifampicin) administered for 4 months in most patients (with the exception of those with meningeal or osteoarticular TB) for the entire period under study.

We stored and processed the data in a Microsoft Office Excel relational database. We summarised qualitative variables as proportions, and quantitative variables as median and interquartile range. We classified patients based on their age at diagnosis: 12 years or less, and older than 12 years. In the bivariate analysis, we studied the association of qualitative variables by means of the chi square test or Fisher's exact test (SPSS version 17.0); we defined statistical significance as a P-value of less than 0.05.


We did a retrospective study of 124 cases of TB disease (male, 56.5%; median age [interquartile range] at diagnosis, 4.0 [2.4–9.6] years), out of which 19 (male, 36.8%) corresponded to patients aged more than 12 years at the time of diagnosis. Table 1 summarises the main characteristics of both groups of patients (≤12 years and >12 years).

Table 1.

Main demographic, clinical, radiologic, microbiological characteristics and treatment and outcome of TB disease in the overall case series and in the under-12 and over-12 years age groups.

  Total (n=124)  Age12 years (n=105)  Age>12 years (n=19)  P 
Male sex  70 (56.5)  63 (60.0)  7 (36.8)  0.006 
Age at diagnosis; median (IQR), in years  4.0 (2.4–9.6)  3.5 (2.0–5.7)  14.9 (13.8–16.3)  <0.0001 
Immigrant patient  39 (31.4)  26 (24.8)  13 (68.4)  <0.0001 
Patient of immigrant descent born in Spaina  66 (53.2)  53 (50.5)  13 (68.4)  NS 
Presence of BCG vaccine scar  19 (15.3)  8 (7.6)  11 (57.9)  <0.0001 
Reason for diagnosis
Clinical-radiological suspicion  73 (58.9)  55 (52.4)  18 (94.7)  0.004 
Contact investigation  42 (34.7)  41 (39.0)  1 (5.3)   
Immigrant patient protocol  9 (7.2)  9 (8.6)  0 (0.0)   
Comorbidity at diagnosis  5 (4.0)  2 (1.9)  3 (15.8)  0.028 
Known index case  64 (51.6)  60 (57.1)  4 (21.1)  0.004 
Induration of TB skin test; median (IQR), in mm  19 (12–20)  20 (16–20)  15 (11–20)  NS 
Positive tuberculin skin test  111 (89.5)  95 (90.5)  16 (84.2)  NS 
Intrathoracic disease  114 (91.9)  97 (92.4)  17 (89.5)  NS 
Cavitary TB  4 (3.2)  1 (0.9)  3 (15.8)  0.002 
Extrathoracic disease  18 (14.5)  16 (15.2)  2 (10.5)  NS 
Severe diseaseb  10 (8.0)  9 (8.6)  1 (5.3)  NS 
Required corticosteroid therapy  14 (11.3)  14 (13.3)  0 (0)  NS 
Required DOT  10 (8.1)  9 (8.6)  1 (5.3)  NS 
Total treatment duration; median (IQR), en months  6 (6.0–9.0)  6 (6.0–6.0)  6 (6.0–9.0)  NS 
Cure outcome  122 (98.4)  103 (98.1)  19 (100)  NS 

BCG, bacillus Calmette-Guérin; IQR, interquartile range; DOT, directly observed therapy; MTB, Mycobacterium tuberculosis; NS, not significant.

Results expressed as n (%) unless noted otherwise.


Includes immigrant patients.


According to Wiseman et al.,4 severe intrathoracic disease includes expansile alveolar opacification, cavitation, empyema or pericarditis, while all forms of extrathoracic disease are severe except tuberculous adenitis or immune-mediated responses such as erythema nodosum.

In patients born to immigrants (n=66), the predominant regions of origin were Morocco (43.1%) and Latin America (30.8%). The diagnosis was made following clinical or radiological suspicion in 58.9% of the cases; the index case was identified in 64 patients (51.6%), in 22 through the investigation of contacts of the secondary paediatric case. Five patients had significant comorbidities at the time of TB diagnosis: Down syndrome, acute lymphoblastic leukaemia under ongoing treatment, homozygous mutation of protein MyD88, cystic fibrosis and superinfection by Pseudomonas aeruginosa of a synthetic prosthesis in the buttock. Primary TB infection was the predominant clinical and radiological presentation (n=95, 76.6%). Cultures were positive to Mycobacterium tuberculosis in only 37.9% of the patients, and in all cases, the isolated strain was sensitive to first-line antibiotics, but for one patient of Peruvian ancestry, who was infected by a strain with single-drug resistance to streptomycin. Fourteen patients (11.3%) also received corticosteroids, most of them on account of neurologic involvement (n=6) or paradoxical reaction after initiation of anti-TB treatment (n=6). Only two patients did not recover in full: one boy aged 4 years with Down syndrome and tuberculous meningitis that developed raised intracranial pressure and extensive brain lesions, who died; and a girl aged 9 years with no relevant medical history with tuberculous meningitis and residual visual field defects secondary to a hypothalamic chiasmatic tuberculoma, who remains in followup.

Compared to patients aged 12 years or less (Table 1), TB disease in adolescents was more prevalent in women (63.2%) and immigrants (68.4%), and 21.1% had comorbidities at the time of diagnosis. Furthermore, the diagnosis was made following clinical or radiological suspicion in most cases, and cavitary pulmonary forms were most prevalent. On the other hand, the index case was identified in only 21.1% of these patients.


The incidence of TB in Spain in 2013 was 11.9 cases per 100,000 inhabitants, 8.3% less than in 2012. The notified cases included 383 patients aged less than 14 years and 498 patients aged 15 to 24 years.5 In the Health Area of Barcelona Sud, the mean incidence of TB in individuals aged 12 years or less and individuals aged 12–18 years in the 2010–2014 period was 8.4 and 8.6 cases per 100,000 inhabitants, respectively. However, the incidence of sputum-smear positive TB in these same age groups was 0.4 and 3.5 cases per 100,000 inhabitants.

The main characteristics of this case series were similar to those described in recent studies in low-incidence TB countries of national6 as well as international7 scope. In our study, paediatric TB predominantly affected previously healthy preschoolers, with an immigrant background in 50–70% of cases, and was diagnosed in the context of a contact investigation or following clinical or radiological suspicion in similar proportions. Most patients had intrathoracic forms of disease that in most cases, fortunately, responded to first-line anti-TB agents and were cured with appropriate treatment.6 Children with TB are considered sentinel cases of community outbreaks; in our series, the diagnosis of TB in children allowed the subsequent identification of 22 (17.7%) contagious index cases.

In adolescents, TB can develop over one to three years following primary infection, or due to reactivation of childhood TB.2,3,8 Recent studies of school outbreaks have demonstrated that primary TB infection can also manifest with upper lung involvement with consolidation, nodules and cavitation9 in the form of disease known as ATpTB. Compared to young children, ATpTB in adolescents usually manifests with overt respiratory symptoms and detection of bacilli in sputum.2,3 Although the number of adolescents with cavitary TB in our study was small, the differences between groups were significant; furthermore, the only patient with cavitary disease in the 12-and-under group was 10.9 years of age at the time of diagnosis. Our series demonstrates that contagious cavitary TB can occur in school-aged children and adolescents, which carries important repercussions at the public health level.

In our case series, two-third of adolescent patients had an immigrant background, which also explains the significant differences in the BCG vaccination status and the rate of identification of index cases in adolescents compared to younger children. The other key difference is that diagnosis in nearly all adolescents resulted from clinical or radiological suspicion. These two aspects are highly relevant to public health. First of all, it can be assumed that adolescents with ATpTB have already put their household and school contacts at risk of infection by the time of diagnosis, as has already been described in other studies conducted in low-incidence countries.10 Furthermore, the social networks of adolescents tend to be broader than those of children, so the number of contacts at risk of infection is also higher.11 Secondly, if we assume that some of these patients became infected in their countries of origin, the subsequent development of TB disease reveals flaws in the health screening system for new immigrants, as it failed to detect cases of latent TB.

Another common characteristic of TB in adolescents and adults is the higher prevalence of comorbidities at the time of diagnosis, which also carries a higher risk of TB-related morbidity and mortality.5 In our case series we did find significant differences in prevalence between the groups, but found no association between comorbidity and disease outcome. In Spain, TB of any location is the most prevalent AIDS-defining disease in the adult population along with Pneumocystis jirovecii pneumonia.12 In the absence of other risk factors, HIV antibody tests are not commonly requested in paediatric patients with TB; recently, de Pontual et al.13 reported a 13% rate of HIV coinfection, especially in adolescents of African origin or with extrapulmonary or severe forms of TB. Although concurrent HIV infection is rare, given the enormous improvements in outcome associated with its early diagnosis, it would be advisable to test TB patients of immigrant backgrounds or with severe forms of disease for HIV.

In the absence of directly observed therapy, adolescence is one of the classic risk factors for poor adherence to anti-TB treatment.14 In our study, we did not have access to specific data on adherence to anti-TB treatment. Nevertheless, the TB cure percentages after completion of treatment exceeded 95% in both age groups, which demonstrates that adherence was adequate in adolescents, as has been reported recently by other case series.10,11,13,15

There are various limitations to our retrospective study. The low number of adolescent patients included in the study may have decreased the possibility of finding an existing association. In addition, a culture of respiratory secretions was not performed in all patients, either due to its low yield or because the drug sensitivity of the index-case strain was known. Both of these circumstances are more common in patients aged 12 years or less, which may have resulted in performance bias. The tuberculin skin test, which continues to be the main tool used in the diagnosis of TB in children, was negative in 13 out of 124 patients (10.5%). During the period under study, interferon-gamma release assays and molecular diagnostic tests, which have increased the probability of obtaining a certain diagnosis of TB in the paediatric age group in recent years, were not yet available in our hospital.

In conclusion, in low-incidence countries, TB in adolescents usually presents as ATpTB, is associated with comorbidities, and is often diagnosed late, which carries a higher risk of transmission to contacts of the patient. Early diagnosis and treatment monitoring, as well as community-based interventions to prevent the transmission of adolescent TB, are the joint responsibility of the health authorities and paediatricians, who should be aware of the particular characteristics of ATpTB.

Conflict of interests

The authors have no conflict of interests to declare.

Red Española de Estudio de la Tuberculosis Pediátrica (pTBred). Available in: [accessed 01.02.16].
B.J. Marais, R.P. Gie, H.S. Schaaf, A.C. Hesseling, C.C. Obihara, J.J. Starke, et al.
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.
Int J Tuberc Lung Dis, 8 (2004), pp. 392-402
C.M. Perez-Velez, B.J. Marais.
Tuberculosis in children.
N Engl J Med, 367 (2012), pp. 348-361
C.A. Wiseman, R.P. Gie, J.R. Starke, H.S. Schaaf, P.R. Donald, M.F. Cotton, et al.
A proposed comprehensive classification of tuberculosis disease severity in children.
Pediatr Infect Dis J, 31 (2012), pp. 347-352
Centro Nacional de Epidemiología, Instituto de Salud Carlos III.
Informe epidemiológico sobre la situación de la tuberculosis en España. Año 2013. Madrid.
B. Santiago, F. Baquero-Artigao, A. Mejías, D. Blázquez, M.S. Jiménez, M.J. Mellado-Peña, et al.
Pediatric drug-resistant tuberculosis in Madrid: family matters.
Pediatr Infect Dis J, 33 (2014), pp. 345-350
I. Abubakar, M.T. Laundy, C.E. French, D. Shingadia.
Epidemiology and treatment outcome of childhood tuberculosis in England and Wales: 1999–2006.
Arch Dis Child, 93 (2008), pp. 1017-1021
P.R. Donald, B.J. Marais, C.E. Barry III.
Age and the epidemiology and pathogenesis of tuberculosis.
Lancet, 375 (2010), pp. 1852-1854
W.J. Koh, Y.J. Jeong, O.J. Kwon, H.J. Kim, E.H. Cho, W.J. Lew, et al.
Chest radiographic findings in primary pulmonary tuberculosis: observations from high school outbreaks.
Korean J Radiol, 11 (2010), pp. 612-617
A. Steppacher, I. Scheer, C. Relly, B. Začek, A. Turk, E. Altpeter, et al.
Unrecognized pediatric adult-type tuberculosis puts school contacts at risk.
Pediatr Infect Dis J, 33 (2014), pp. 325-328
A.T. Cruz, K.M. Hwang, G.D. Birnbaum, J.R. Starke.
Adolescents with tuberculosis: a review of 145 cases.
Pediatr Infect Dis J, 32 (2013), pp. 937-941
Área de Vigilancia de VIH y Conductas de Riesgo.
Vigilancia Epidemiológica del VIH/sida en España: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Madrid: Plan Nacional sobre el Sida – S. G. de Promoción de la Salud y Epidemiología/Centro Nacional de Epidemiología – ISCIII.
L. De Pontual, L. Balu, P. Ovetchkine, B. Maury-Tisseron, E. Lachassinne, P. Cruaud, et al.
Tuberculosis in adolescents: a French retrospective study of 52 cases.
Pediatr Infect Dis J, 25 (2006), pp. 930-932
E.M. Guix-Comellas, L. Rozas-Quesada, E. Force-Sanmartín, J.M. Estrada-Masllorens, J. Galimany-Masclans, A. Noguera-Julian.
Influence of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: research protocol.
J Adv Nurs, 71 (2015), pp. 2189-2199
B.J. Marais, R.P. Gie, A.H. Hesseling, N. Beyers.
Adult-type pulmonary tuberculosis in children 10–14 years of age.
Pediatr Infect Dis J, 24 (2005), pp. 743-744

Please cite this article as: Margarit A, Simó S, Rozas L, Deyà-Martínez À, Barrabeig I, Gené A, et al. Tuberculosis en el adolescente; reto y oportunidad de evitar el contagio a la comunidad. An Pediatr (Barc). 2017;86:110–114.

Previous presentation: Partial results of this study were presented at the VII Congress of the Sociedad Española de Infectología Pediátrica (Spanish Society of Paediatric Infectious Diseases [SEIP]); March 2014; Santiago de Compostela, Spain.

Copyright © 2016. Asociación Española de Pediatría
Anales de Pediatría (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.